Clinical studies have revealed reductions in cholinesterase activity, as well as decreased synthesis, release, and uptake of acetylcholine (ACh) in regions of the brain associated with cognitive function, such as the hippocampus and cortex, in AD patients [73]. Here, BCHE is linked to Alzheimer disease.